SEMA4D Blockade Safety and Brain Metabolic Activity in Alzheimer's Disease (AD)

Clinical trial NCT04381468 · COMPLETED

Trial details

NCT number: NCT04381468
Sponsor: Vaccinex Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2021-07-22
Primary completion: 2024-06-05
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.